Prevalence of urinary tract infection and the molecular characterization with special reference to fim h gene in uropathogenic e. Coli isolated from urine samples at a tertiary care hospital
Keywords:
UTI, CLSI, Molecular characterization, fimH , DNA, PCRAbstract
BACKGROUND
Urinary tract infections, or UTIs, are common diseases caused by bacteria that enter the urethra from the skin or rectum. Urinary tract infections account for the majority of hospital visits worldwide and are a significant contributor to morbidity and comorbidity in individuals with underlying medical disorders. Uropathogenic Escherichia coli (UPEC) express a multitude of virulence factors (VFs) to break the inertia of the mucosal barrier of the urinary tract UPEC strains are the most common pathogens, accounting for 85% and 50% of community and hospital-acquired UTIs. UPEC strains have unique virulence characteristics, including type 1 fimbriae, which can result in worsening of UTIs.
AIM AND OBJECTIVE
A study on prevalence of urinary tract infection of uropathogenic E.coli and the molecular characterization with special reference to fim H gene from urine samples.
MATERIAL & METHODS
This was a cross-sectional study carried out in the Department of Microbiology at a tertiary care hospital for a period of 12 months i.e, 2024 to 2025. A total of 200 Patients were screened from 600 clinical isolates where 200 were positive of all the age groups and both sex with indwelling urinary catheters for at least 2 days, who were suffering from the symptoms of UTIs (fever > 38ºC, urgency, frequency dysuria or suprapubic tenderness) were included in this study. The Antibiotic Susceptibility testing was performed according to the CLSI guidelines 2024. If delayed, samples were refrigerated and processed within 4-6 hrs. The identification, biochemicals and the AST pattern was done according to the CLSI guidelines 2024. The DNA was extracted using the Qiagen DNA Extraction kit and the FIM H gene was detected by the conventional PCR assay.
RESULTS
In the present study a total of 600 clinically suspected cases were screened out of which total 200 isolates was found positive for UTI infection . Therefore, the prevalence rate of UTI was found to be 33%. From the present study it was observed that the Females 114 (57%) were more affected with the infection as compared to the Males 86 (43%). It was also noted that the age group of 31-40 years of age followed by 41-50 years was affected the most. In the age group of 0-10 years, 11-20 years and above 71 years was the least affected with the infection. In the current study E.coli (31%) was the most common followed by Klebsiella spp.(24%), Pseudomonas aeruginosa (18%), Staphylococcus aureus (7.5%), Acinetobacter baumanii (9%), Proteus (5.5%), Enterococcus (5.5%).
In the present study the resistant rate for Ampicillin was observed to be 75% followed by Co-trimoxazole (92.5%) . Imipenem and Nitrofurantoin were sensitive with 89%. There were other research investigators whose finding were parallel to the current study where Enterobacteriaceae showed high resistant to commonly used antimicrobials. In the current study there was fim H gene studied. In the fim H gene there were 165 (82.5%) positive cases and negative were 35 (17.5%).
CONCLUSION
This study found that UTIs were more common in women than in men. The most common symptoms, such as chills, dysuria, and abdominal pain, were reported in patients with urinary tract infections. Therefore, regular exams and strict adherence to antibiotic stewardship recommendations can lower the cost of UTI prophylaxis. By performing these routine tests, the expense of avoiding UTIs can be decreased.x
Downloads
Metrics
References
Anger J., Lee U., Ackerman A.L., et al. Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline. J Urol. 2019; 202:282–289.
Shigemura K., Ishikawa K. AAUS guideline for acute uncomplicated pyelonephritis. J Infect Chemother. 2022; 28:1092–1097.
Maria E. Terlizzi, Giorgio Gribaudo, and Massimo E. Maffei. UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies. Frontiers of Microbiology. 2017; 8:1566.
F. S. Nas, M. Ali, M. S. Abdallah, and A. U. Zage, Prevalence and antibiotic susceptibility pattern of Escherichia coli isolated from urine samples of urinary tract infection patients. ARC Journal of Urology. 2019; 4(1). 36: 100716
M. Gajdács, M. Ábrók, A. Lázár, and K. Burián, “Comparative epidemiology and resistance trends of common urinary pathogens in a tertiary-care hospital: a 10-year surveillance study,” Medicina. 2019; 55(7).
M. Gajdács and E. Urbán, “Resistance trends and epidemiology of citrobacter-enterobacter-serratia in urinary tract infections of inpatients and outpatients (RECESUTI): a 10-year survey,”. Medicina. 2019; 55(6):1–13.
Marantidis J., Sussman R.D. Unmet needs in complicated urinary tract infections: challenges, recommendations, and emerging treatment pathways. Infect Drug Resist. 2023;16:1391–1405.
Jaggi N, Sissodia P. Multimodal supervision programme to reduce catheter associated urinary tract infections and its analysis to enable focus on labour and cost effective infection control measures in a tertiary care hospital in India. J Clin Diagn Res. 2012; 6:1372– 6.
Teh AH, Wang Y, Dykes GA. The influence of antibiotic resistance gene carriage on biofilm formation by two Escherichia colistrains associated with urinary tract infections. Can J Microbiol. 2014; 60:105-11.
Rashki A, Abdi HA, Shookohi M. Prevalence of genes encoding outer membrane virulence factors among fecal Escherichia coli isolates. Int J Basic Sci Med. 2017; 2(1):52–7.
Neamati F, Firoozeh F, Saffari M, Zibaei M. Virulence genes and antimicrobial resistance pattern in uropathogenic Escherichia coli isolated from hospitalized patients in Kashan, Iran. Jundishapur J Microbiol. 2015; 8(2). e17514.
Momtaz H, Karimian A, Madani M, Safarpoor Dehkordi F, Ranjbar R, Sarshar M, et al. Uropathogenic Escherichia coli in Iran: serogroup distributions, virulence factors and antimicrobial resistance properties. Ann Clin Microbiol Antimicrob. 2013;12:8.
Behzadi P, Urban E, Gajdacs M. Association between biofilmproduction and antibiotic resistance in uropathogenic Escherichia coli (UPEC): an in vitro study. Diseases. 2020; 8(2).
Katongole P, Nalubega F, Florence NC, Asiimwe B, Andia I. Biofilm formation, antimicrobial susceptibility and virulence genes of Uropathogenic Escherichia coli isolated from clinical isolates in Uganda.BMC Infect Dis. 2020; 20(1):453.
De Alegria Puig, C.R, Pilares, L, Marco, F, Vila, J, Martinez-Martinez, L, NNavas, J. Comparison of the Vitek MS and Bruker Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Systems for Identification of Rhodococcus equi and Dietzia spp. J. Clin. Microbiol. 2017; 55, 2255–2260.
Gabriel Kambale Bunduk, Eva Heinz , Vincent Samuel Phiri , Patrick Noah , Nicholas Feasey, and Janelisa Musaya. Virulence factors and antimicrobial resistance of uropathogenic Escherichia coli (UPEC) isolated from urinary tract infections: a systematic review and metaanalysis. BMC Infectious Diseases . 2021; 21:753. https://doi.org/10.1186/s12879-021-06435-7
Chhaya Shah, Ratna Baral, Bijay Bartaula & Lok Bahadur Shrestha .Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance. BMC. Infectious Diseases. 2019; 19(204): 1587-3 .
Sabir N, Ikram A, Zaman G, Satti L, Gardezi A, Ahmed A, Ahmed P. Bacterial biofilm-based catheter-associated urinary tract infections: Causative pathogens and antibiotic resistance. Am J Infect Control. 2017; S0196-6553(17)30693-4.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty Sixth Informational Supplement, CLSI Document M100S-26. Wayne, PA: Clinical and Laboratory Standards Institute 2024.
Nina M. Poole et al. Role for FimH in Extraintestinal Pathogenic Escherichia coli Invasion and Translocation through the Intestinal Epithelium. • ASM Journals• Infection and Immunity. 2017; Vol. 85, No. 11
Brumbaugh AR, Smith SN, Mobley HL. Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection. Infect Immun. 2013; 81(9):3309–16.
Ghimire A, Pradeep. Pattern of Antibiotic Resistance Bacteria isolated from various Clinical Specimens.. IOSR Journal of Dental and Medical Sciences. 2018; 17. 40-42.
Mohapatra A, Sarita et al. “Prevalence and resistance pattern of uropathogens from community settings of different regions: an experience from India.” Access microbiology. 2022; 4 (2) :000321
Mlugu, E.M., Mohamedi, J.A., Sangeda, R.Z. et al. Prevalence of urinary tract infection and antimicrobial resistance patterns of uropathogens with biofilm forming capacity among outpatients in morogoro, Tanzania: a cross-sectional study. BMC Infect . 2023; Dis 23, 660
.Hawra Al Lawati et al. Urinary Tract Infections: Core Curriculum 2024.
Akhtar A, Ali et al. “A Cross-Sectional Assessment of Urinary Tract Infections Among Geriatric Patients: Prevalence, Medication Regimen Complexity, and Factors Associated With Treatment Outcomes.” Frontiers in public health. 2021; 9 : 657199.
Karishetti M, Mallikarjun S.; Shaik, Hussain Basha. Clinicomicrobial assessment of urinary tract infections in a tertiary care hospital. Indian Journal of Health Sciences and Biomedical Research (KLEU) . 2019; 12(1): 69-74.
Mythri Set al. “Urinary Tract Infection in Chronic Kidney Disease Population: A Clinical Observational Study.” Cureus . 2021; 13 (1) .12486
Shah L, Vaghela G, Mahida H Urinary tract infection: bacteriological profile and its antibiotic susceptibility in western India.. http://njmr.in/uploads/5-1_71-74.pdf Nat J Med Res. 2015;5:71–74.
Tuem KB, Desta R, Bitew H, Ibrahim S, Hishe HZ. Antimicrobial resistance patterns of uropathogens isolated between 2012 and 2017 from a tertiary hospital in Northern Ethiopia. J Global Antimicrob Resist. 2019;18:109–114.
Gajamer VR, Bhattacharjee A, Paul D, et al. High prevalence of carbapenemase, AmpC β-lactamase and aminoglycoside resistance genes in extended-spectrum β-lactamase-positive uropathogens from Northern India. J Global Antimicrob Resist. 2020; 20:197–203.
Ahmad S, Ahmad F. Urinary tract infection at a specialist hospital in Saudi Arabia. Bangladesh Med Res Counc Bull .1995; 21:95-8.
Syed Suhail Ahmed, Ali Shariq, Abdulaziz Ajlan Alsalloom, Ibrahim H. Babikir, Badr N. Alhomoud. Uropathogens and their antimicrobial resistance patterns: Relationship with urinary tract infections. International Journal of Health Sciences. 2019; Vol. 13, Issue 2 .
H Hyun M, Lee JY, Kim HA. Differences of virulence factors, and antimicrobial susceptibility according to phylogenetic group inuropathogenic Escherichia coli strains isolatedfromKorean patients. Research Square. 2021: 10; 20(1):77.
Mostafa Boroumand , Asghar Sharifi , Mohammad Amin Ghatei and Mohsen Sadrinasab. Evaluation of Biofilm Formation and Virulence Genes and Association with Antibiotic Resistance Patterns of UropathogenicEscherichia coli Strains in Southwestern Iran. Jundishapur J Microbiol. 2021 September; 14(9):e117785.
Adnan Malooh Jaber and Hasan A. Aal Owaif. Detection of genes involved in biofilms formation by Escherichia coli isolated from patients suffering of urinary tract infections. plant archives. 2020; 20 (2) :5987-5992.
Belayneh Regasa Dadi, Tamrat Abebe, Lixin Zhang, Adane Mihret, Workeabeba Abebe and WondwossenAmogne, Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa, Ethiopia; BMC Infectious Diseases. 2020; 20:108.
Salih, E.G.M., M.I. Nader and M.N. Rasheed .RapidDetection of Uropathogenic Escherichia Coli virulencefactors in Iraqi patients by multiplex polymerase chain Reaction. 2015
Hojati, Z., B. Zamanzad, M. Hashemzadeh, R. Molaie and A.Gholipour . Detection of fimh gene in uropathogenicescherichia coli strains isolated from patients with urinary tract infection. Jundishapur Journal of Microbiology. 2015; 8(2): 12-15.
Merza, N.S. Prevalence and Molecular Characterizationof Fim H Gene in Escherichia Coli Isolates RecoveredFrom Patients With Utis. Medical Journal of Babylon. 2017; 14(3): 470–477.
Taai, H.R.R., Z.A.S. Al-Jebouri, B.H. Khalaf and Y.Q.Mohammed . Antibiotic resistance patterns andadhesion ability of uropathogenic Escherichia coli in children. Iraqi Journal of Biotechnology. 2018; 17(1): 18-26.
Bonkat G., Bartoletti R., Bruyère F., et al. European Association of Urology; Arnhem, The Netherlands: 2024. EAU guidelines on urological infections.
Gernot Bonkat et al. Classification of Urinary Tract Infections in 2025: Moving Beyond Uncomplicated and Complicated. Eur Urol Open Sci. 2025 Apr 6; 75:44–47.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

